1CM Management

Management criteria checks 1/4

1CM's CEO is Tanvi Bhandari, appointed in Mar 2022, has a tenure of 2.08 years. directly owns 12.74% of the company’s shares, worth CA$15.00M. The average tenure of the management team and the board of directors is 2.1 years and 2.1 years respectively.

Key information

Tanvi Bhandari

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	2.1yrs
CEO ownership	12.7%
Management average tenure	2.1yrs
Board average tenure	2.1yrs

Recent management updates

Recent updates

What You Can Learn From 1CM Inc.'s (CSE:EPIC) P/S

Feb 07

Investors Appear Satisfied With 1CM Inc.'s (CSE:EPIC) Prospects

Jun 27

CEO

Tanvi Bhandari

2.1yrs

Tenure

Ms. Tanvi Bhandari is Chief Executive Officer and Director of 1CM Inc. (formerly known as Leviathan Natural Products Inc.) from March 07, 2022. She joined 1CM Inc. (formerly known as Leviathan Natural Prod...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Tanvi Bhandari	CEO & Director	2.1yrs	no data	12.74% CA$ 15.0m
Linda Romano	Chief Financial Officer	1.6yrs	no data	no data
Harshil Chovatiya	COO & Corporate Secretary	2.1yrs	no data	0.13% CA$ 152.3k
Kamyar Hosseini	Head of Technology	no data	no data	no data

2.1yrs

Average Tenure

Experienced Management: EPIC's management team is considered experienced (2.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Tanvi Bhandari	CEO & Director	2.1yrs	no data	12.74% CA$ 15.0m
Rupalee Mehta	Independent Director	2.1yrs	no data	no data
Lucas Leone	Independent Director	2.1yrs	no data	0.0085% CA$ 10.0k

2.1yrs

Average Tenure

Experienced Board: EPIC's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.

1CM Management

Management criteria checks 1/4

Key information

Recent management updates

High number of new and inexperienced directors

Leviathan Natural Products Inc., Annual General Meeting, Sep 06, 2022

No independent directors

Insufficient new directors

Insufficient new directors

Recent updates

New minor risk - Market cap size

New minor risk - Share price stability

What You Can Learn From 1CM Inc.'s (CSE:EPIC) P/S

First quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.003 profit in 1Q 2023)

Full year 2023 earnings released: CA$0.008 loss per share (vs CA$0.054 loss in FY 2022)

1Cm Inc. Expands its Operations Adding Tobacco, CPG, Private Label Products

Third quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.012 loss in 3Q 2022)

1CM Inc. (CNSX:EPIC) acquired Fresh Cannabis Co. Inc. from Cost Cannabis Inc. for CAD 0.38 million.

Investors Appear Satisfied With 1CM Inc.'s (CSE:EPIC) Prospects

Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.012 loss in 2Q 2022)

Full year 2022 earnings released: CA$0.054 loss per share (vs CA$0.055 loss in FY 2021)

1CM Inc. (CNSX:EPIC) acquired remaining 35% stake of LCG Holdings, Inc.

High number of new and inexperienced directors

1CM Inc. announced that it expects to receive CAD 5.8 million in funding

An unknown buyer acquired Woodstock Biomed Inc. from Leviathan Natural Products Inc. (CNSX:EPIC) for CAD 5 million.

Third quarter 2022 earnings released: CA$0.012 loss per share (vs CA$0.011 loss in 3Q 2021)

Leviathan Natural Products Inc., Annual General Meeting, Sep 06, 2022

Leviathan Natural Products Inc. (CNSX:EPIC) acquired One Cannabis Market Inc. for CAD 0.52 million.

Second quarter 2022 earnings released: CA$0.012 loss per share (vs CA$0.011 loss in 2Q 2021)

No independent directors

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Insufficient new directors

Insufficient new directors

Leviathan Natural Products Inc. (CNSX:EPIC) acquired Natural Origins SAS for approximately COP 500 million

New 90-day high: CA$0.52

New 90-day high: CA$0.48

New 90-day high: CA$0.36

New 90-day high: CA$0.22

New 90-day high: CA$0.21

CEO

Tenure

Leadership Team

Average Tenure

Board Members

Average Tenure